The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)
Women in weight loss studies tend to be more consistent with the medication and more likely to pair it with lifestyle changes like tracking food and walking more
Temporarily limit high-protein foods like red meat and eggs, cruciferous vegetables (broccoli, cauliflower), allium vegetables (onions, garlic), dairy products, carbonated beverages, and sugar alcohols found in sugar-free products
The results of the trial were published in Annals of Internal Medicine on June 30
Meanwhile, Pfizer is developing an oral GIP analogue, currently known as PF-07976016, which is to be administered daily
Other GLP-1 Pills in the Pipeline Although Wegovy is the first GLP-1 pill the FDA has approved for weight management, drug manufacturers are funding trials for additional oral GLP-1 medications
